COX JOHN (CEO & President) sold 0.7% of their position (2.68K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $49.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2026ACC: 0001498428-26-000002
DirectorOfficer· CEO & President
Since Mar 2026
-2.68K
Net shares
Net seller
$49.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.68K
Price / share
$18.33
Trade value
$49.18K
% of position
0.7%
6/16/2026
370.83K→368.15K
Total
Net shares
−2.68K
Net value
-$49.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | S · Sale | −2.68K | $18.33 | $49.18K | 0.7% | 370.83K | 368.15K |
| Total | −2.68K | -$49.18K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Total
72K indirect72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Total | 72K | 72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported